Overview

IMUNOR® Preparation in the Prevention of COVID-19

Status:
Completed
Trial end date:
2021-06-02
Target enrollment:
Participant gender:
Summary
The aim of the study is to achieve prevention of COVID-19 disease in healthcare professionals with the administration of the IMUNOR® preparation, and decreasing the symptoms should the disease appear.
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital Ostrava